mitomycin has been researched along with Carcinoma, Adenosquamous in 13 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Carcinoma, Adenosquamous: A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and toxicity of the combination of mitomycin C, etoposide, cisplatin, and epirubicin (MEPA) as neoadjuvant therapy for patients with cervical adenocarcinoma." | 7.72 | A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix. ( Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K, 2004) |
| "Between May 1990 and February 1995, 16 patients with adenocarcinoma or adenosquamous carcinoma of the uterine cervix were prescribed neoadjuvant chemotherapy consisting of cisplatin (50 mg/m2) on day 1, mitomycin C (10 mg/m2) on day 1, and etoposide (100 mg/m2) on days 1, 3, and 5 (MEP)." | 7.70 | Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. ( Fukuda, K; Hara, K; Iwasaka, T; Nakao, Y; Sugimori, H; Uchiyama, M; Yokoyama, M, 1998) |
| "To evaluate the efficacy and toxicity of the combination of mitomycin C, etoposide, cisplatin, and epirubicin (MEPA) as neoadjuvant therapy for patients with cervical adenocarcinoma." | 3.72 | A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix. ( Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K, 2004) |
| "Between May 1990 and February 1995, 16 patients with adenocarcinoma or adenosquamous carcinoma of the uterine cervix were prescribed neoadjuvant chemotherapy consisting of cisplatin (50 mg/m2) on day 1, mitomycin C (10 mg/m2) on day 1, and etoposide (100 mg/m2) on days 1, 3, and 5 (MEP)." | 3.70 | Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. ( Fukuda, K; Hara, K; Iwasaka, T; Nakao, Y; Sugimori, H; Uchiyama, M; Yokoyama, M, 1998) |
| "Among patients with uterine cervical cancer, glassy-cell carcinoma is very rare." | 1.31 | Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C. ( Ezawa, S; Fukuchi, T; Komuro, Y; Mikami, M; Mukai, M; Sakaiya, N; Tei, C, 2000) |
| "The response rate was higher in squamous cell carcinomas (85%) than adenocarcinomas or adenosquamous carcinomas (67%)." | 1.30 | [Neoadjuvant chemotherapy for advanced cervical cancer]. ( Hongo, A; Ikuhashi, H; Kobashi, Y; Kodama, J; Kudo, T; Miyagi, Y; Mizutani, Y; Okuda, H; Yoshinouchi, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graf, R | 1 |
| Wust, P | 1 |
| Hildebrandt, B | 1 |
| Gögler, H | 1 |
| Ullrich, R | 1 |
| Herrmann, R | 1 |
| Riess, H | 1 |
| Felix, R | 1 |
| Ivanov, S | 2 |
| Zervoudis, S | 1 |
| Tabata, T | 1 |
| Nishiura, K | 1 |
| Yanoh, K | 1 |
| Okugawa, T | 1 |
| Obata, H | 1 |
| Tanaka, K | 1 |
| Toyoda, N | 1 |
| Takeshima, N | 1 |
| Umayahara, K | 1 |
| Fujiwara, K | 1 |
| Hirai, Y | 1 |
| Takizawa, K | 1 |
| Hasumi, K | 1 |
| Christie, DR | 1 |
| Bull, CA | 1 |
| Gebski, V | 1 |
| Langlands, AO | 1 |
| Rakovitch, E | 1 |
| Fyles, AW | 1 |
| Pintilie, M | 1 |
| Leung, PM | 1 |
| Kaneyasu, Y | 1 |
| Okawa, MK | 1 |
| Kokubo, N | 1 |
| Karasawa, K | 1 |
| Fukuhara, N | 1 |
| Toda, J | 1 |
| Okawa, T | 1 |
| Iwasaka, T | 2 |
| Kamura, T | 1 |
| Yokoyama, M | 2 |
| Matsuo, N | 1 |
| Nakano, H | 1 |
| Sugimori, H | 2 |
| Fukuda, K | 1 |
| Hara, K | 1 |
| Nakao, Y | 1 |
| Uchiyama, M | 1 |
| Kodama, J | 1 |
| Ikuhashi, H | 1 |
| Hongo, A | 1 |
| Mizutani, Y | 1 |
| Miyagi, Y | 1 |
| Yoshinouchi, M | 1 |
| Kobashi, Y | 1 |
| Okuda, H | 1 |
| Kudo, T | 1 |
| Mikami, M | 1 |
| Ezawa, S | 1 |
| Sakaiya, N | 1 |
| Komuro, Y | 1 |
| Tei, C | 1 |
| Fukuchi, T | 1 |
| Mukai, M | 1 |
| Shimizu, Y | 1 |
| Shigematsu, T | 1 |
| Ohishi, Y | 1 |
| Fujita, T | 1 |
| Higashihara, J | 1 |
| Irie, T | 1 |
| Hayashi, T | 1 |
1 review available for mitomycin and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleo | 2000 |
2 trials available for mitomycin and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carc | 2003 |
[Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 1997 |
10 other studies available for mitomycin and Carcinoma, Adenosquamous
| Article | Year |
|---|---|
[Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage I B and II A cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Fema | 2003 |
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Comb | 2004 |
Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosquamous; Ca | 2006 |
Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brac | 1995 |
Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplas | 1997 |
Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma: a comparison with effects of adjuvant radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; | 1998 |
Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 1998 |
[Neoadjuvant chemotherapy for advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 1999 |
Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Epirubic | 2000 |
Metastatic carcinoma in a transposed ovary after radical hysterectomy for a stage 1B cervical adenosquamous cell carcinoma. Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposid | 2000 |